Delivery Order SPE2DB22D2108-SPE2DB25FU3BC
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$45K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,004.38 firm fixed-price delivery order is for the supply of MYRBETRIQ ER 50 MG tablets, a medication used to treat overactive bladder. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,357.16 firm fixed-price delivery order is for the supply of 4566722796 MYRBETRIQ ER 50 MG TABLET 90S, a medication used for the treatment of overactive bladder. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,860.06 delivery order contract is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a medication used for the treatment of overactive bladder. The contract has an ultimate completion date of May 8, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $102,022.45 firm-fixed-price delivery order is for the supply of Myrbetriq ER 25 MG tablets, a medication used to treat overactive bladder. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,582.23 firm-fixed-price delivery order is for MYRBETRIQ ER 50 MG TABLET 90S, a medication primarily used for overactive bladder treatment. The award is not designated with a set-aside and represents one of many delivery orders issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,794.90 firm fixed-price delivery order contract is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,258.88 firm fixed-price delivery order is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a medication used in the treatment of overactive bladder. The contract has an ultimate completion date of January 16, 2025 and does not include any set-aside requirements. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,196.85 Firm Fixed Price Delivery Order covers the supply of 4561153185 units of MYRBETRIQ ER 50 MG TABLET 90S, a medication used for the treatment of overactive bladder. The award is not associated with a set-aside program and represents an open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,562.16 firm fixed-price delivery order is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a medication used for the treatment of overactive bladder. The contract has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,085.86 firm fixed-price delivery order is for the provision of MYRBETRIQ ER 50 MG TABLET 90S, a medication used in the treatment of overactive bladder. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...